awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46990125-64532F33-BB76-4F1D-BCC0-077BE7F8FEE6
Q46990125-64532F33-BB76-4F1D-BCC0-077BE7F8FEE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46990125-64532F33-BB76-4F1D-BCC0-077BE7F8FEE6
PD-L1 Assessment for Targeted Therapy Testing in Cancer: Urgent Need For Realistic Economic and Practice Expectations.
P2860
Q46990125-64532F33-BB76-4F1D-BCC0-077BE7F8FEE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46990125-64532F33-BB76-4F1D-BCC0-077BE7F8FEE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
22cbdcc0b2a17e42e54ead11b9db829ca710d8ca
P2860
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.